Sun Pharmaceutical Industries is recalling 747 bottles of generic diabetes drug in the US due to possibility of the affected lot containing cancer causing nitrosodimethylamine (NDMA) above the acceptable intake limit. As per the latest Enforcement Report of the US Food and Drug Administration (USFDA), the company is recalling the bottles of RIOMET ER (metformin hydrochloride for extended-release oral suspension) in the American market.
The company initiated the recall on September 23, 2020. The US health regulator has classified it as a Class-II recall, which is initiated in a ‘situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote’.
Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1871.55 |
| Dr. Reddys Labs. | 1346.25 |
| Cipla | 1456.25 |
| Zydus Lifesciences | 1099.65 |
| Lupin | 2398.70 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: